Results 31 to 40 of about 56,246 (219)
Mildronate in cardiology practice – current evidence, ongoing research, and future perspectives
The review discusses the benefits and various practical aspects of the new cardioprotector mildronate use in cardiology. The latest evidence on the mildronate role in complex therapy of patients with stable angina, or patients in the rehabilitation ...
V. P. Mikhin +3 more
doaj +1 more source
ABSTRACT Background In patients with acute coronary syndrome (ACS) and multivessel disease (MVD), complete revascularization (CR) improves clinical outcomes compared with culprit‐only percutaneous coronary intervention (PCI). However, the optimal timing of CR, immediate (ICR) versus staged (SCR), remains debated.
Alessandro Gabrielli +7 more
wiley +1 more source
VERMONT μQFR: Diagnostic Accuracy of Murray Law‐Based 2D‐μQFR Compared to 3D‐μQFR and vFFR
ABSTRACT Background Murray law‐based quantitative flow ratio (μQFR) is an angiography‐derived physiological index that utilizes a single angiographic projection with artificial intelligence‐guided vessel segmentation. Aims To evaluate the diagnostic accuracy and time efficacy of 2D‐μQFR against wire‐based fractional flow reserve (FFR ≤ 0.80), compare ...
Daniel Akrawi +16 more
wiley +1 more source
Coronary Perforation During Excimer Laser Angioplasty in a Patient With Prior Thoracic Radiotherapy
ABSTRACT Background Management of heavily calcified coronary lesions remains challenging despite advances in plaque‐modifying technologies. Excimer laser coronary angioplasty (ELCA) is an effective adjunctive strategy with a low risk of no‐reflow. Case Summary A 75‐year‐old woman with non–ST‐segment elevation acute coronary syndrome and severe left ...
Francesco Maria Sparasci +3 more
wiley +1 more source
Introduction Trimetazidine (TMZ) is an antianginal agent that acts directly at the myocardial cell level and which is now available in a once-daily (od) formulation.
Maria G. Glezer +2 more
doaj +1 more source
Ranolazine for stable angina pectoris [PDF]
Stable angina pectoris is a chronic medical condition with significant impact on mortality and quality of life; it can be macrovascular or microvascular in origin. Ranolazine is a second-line anti-anginal drug approved for use in people with stable angina.
Carlos A, Salazar +5 more
openaire +2 more sources
ABSTRACT Background There are limited data evaluating the association between operator−patient sex, and outcomes in patients undergoing percutaneous coronary intervention (PCI). Methods We included 138,112 consecutive PCI procedures in patients presenting with acute coronary syndrome (ACS) in England and Wales, 2017−2020.
Sharon A. Ayayo +6 more
wiley +1 more source
Abstract Wild‐type transthyretin amyloid cardiomyopathy (ATTRwt‐CM) is a progressive and infiltrative cardiac disorder that may cause fatal consequences if left untreated. The estimated survival time from diagnosis is approximately 3–6 years. Because of the non‐specificity of initial symptom manifestation and insufficient awareness among treating ...
Yasuhiro Izumiya +9 more
wiley +1 more source
Diagnosis and Management of Chronic Stable Angina: Clinical Guidelines in Primary Care
Target groups: General physicians Educational goals After reading this tutorial, the learner should know the following: • define chronic stable angina • differentiate between acute coronary syndromes and chronic stable angina • identify methods to ...
Mehdi Hashemi, Fatemeh Hadizadeh
doaj
Initial presentation in almost half of the patients with chronic ischemic heart disease (IHD) is chronic stable angina. Despite recent improvements in diagnosis and treatment, IHD still appears to be the most important cause of morbidity and mortality in
Muhsin Kalyoncuoğlu +4 more
doaj +1 more source

